Zobrazeno 1 - 10
of 108
pro vyhledávání: '"TETSUHIKO TAIRA"'
Autor:
Tateaki Naito, Taro Okayama, Takashi Aoyama, Takuya Ohashi, Yoshiyuki Masuda, Madoka Kimura, Hitomi Shiozaki, Haruyasu Murakami, Hirotsugu Kenmotsu, Tetsuhiko Taira, Akira Ono, Kazushige Wakuda, Hisao Imai, Takuya Oyakawa, Takeshi Ishii, Shota Omori, Kazuhisa Nakashima, Masahiro Endo, Katsuhiro Omae, Keita Mori, Nobuyuki Yamamoto, Akira Tanuma, Toshiaki Takahashi
Publikováno v:
BMC Cancer, Vol 17, Iss 1, Pp 1-10 (2017)
Abstract Background Cancer cachexia in elderly patients may substantially impact physical function and medical dependency. The aim of this study was to estimate the impact of cachexia on activity of daily living (ADL), length of hospital stay, and in
Externí odkaz:
https://doaj.org/article/abd84b26cbf7423eaf18ccfafe7d236e
Autor:
Tateaki Naito, Taro Okayama, Takashi Aoyama, Takuya Ohashi, Yoshiyuki Masuda, Madoka Kimura, Hitomi Shiozaki, Haruyasu Murakami, Hirotsugu Kenmotsu, Tetsuhiko Taira, Akira Ono, Kazushige Wakuda, Hisao Imai, Takuya Oyakawa, Takeshi Ishii, Shota Omori, Kazuhisa Nakashima, Masahiro Endo, Katsuhiro Omae, Keita Mori, Nobuyuki Yamamoto, Akira Tanuma, Toshiaki Takahashi
Publikováno v:
BMC Cancer, Vol 17, Iss 1, Pp 1-9 (2017)
Abstract Background Elderly patient with advanced cancer is one of the most vulnerable populations. Skeletal muscle depletion during chemotherapy may have substantial impact on their physical function. However, there is little information about a dir
Externí odkaz:
https://doaj.org/article/6c2353662ec94817a2a26aacd4c865d3
Autor:
Hisao Imai, Keita Mori, Kazushige Wakuda, Akira Ono, Hiroaki Akamatsu, Takehito Shukuya, Tetsuhiko Taira, Hirotsugu Kenmotsu, Tateaki Naito, Kyoichi Kaira, Haruyasu Murakami, Masahiro Endo, Takashi Nakajima, Nobuyuki Yamamoto, Toshiaki Takahashi
Publikováno v:
Annals of Thoracic Medicine, Vol 10, Iss 1, Pp 61-66 (2015)
Objectives: The effects of first-line chemotherapy on overall survival (OS) might be confounded by subsequent therapies in patients with small cell lung cancer (SCLC). We examined whether progression-free survival (PFS), post-progression survival (PP
Externí odkaz:
https://doaj.org/article/05ee01e8bed04280b2bfa6430835de03
Autor:
Reiki Nishimura, Yoshitaka Fujiki, Tetsuhiko Taira, Toshiko Miyaki, Shuichi Kanemitsu, Daisuke Yotsumoto, Megumi Teraoka, Junko Kawano, Naomi Gondo, Reiko Mitsueda, Shinichi Baba, Yasuyo Ohi, Yoshiaki Rai, Yoshiaki Sagara, Yasuaki Sagara
Publikováno v:
Clinical Breast Cancer; Jul2024, Vol. 24 Issue 5, p431-438, 8p
Autor:
Tomoyuki Aruga, Hiroyoshi Doihara, Yasuhiro Yanagita, Takanori Ishida, Toshinari Yamashita, Kanou Uehara, Tetsuhiko Taira, Junji Tsurutani, Takashi Takeshita, Shigeru Tsuyuki, Koji Kaneko, Tohru Ohtake, Yusuke Yamaguchi, Yui Hara, Shigehira Saji
Publikováno v:
Cancer Science. 113:1763-1770
Pegfilgrastim, a pegylated form of granulocyte colony-stimulating factor, has reduced the risk of developing febrile neutropenia, which is associated with an increase in severe infection and prolonged hospitalization. However, pegfilgrastim administr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::28804cd0c1edaf7af132b6dae87a0f23
https://doi.org/10.1111/cas.15335
https://doi.org/10.1111/cas.15335
Autor:
Takafumi Sangai, Yuichiro Kikawa, Mitsuchika Hosoda, Yohei Hamanaka, Yuko Tanabe, Tatsuya Yoshida, Kaori Tane, Daisuke Takabatake, Tetsuhiko Taira, Kazuhiro Araki, Takayuki Iwamoto, Mamoru Takada, Kazutaka Narui, Takeshi Yamaguchi, Akimitsu Yamada, Tomoko Miura, Yukari Uemura, Tomohiko Aihara, Hirofumi Mukai, Naruto Taira
Publikováno v:
Cancer Research. 82:OT1-12
Background: Trastuzumab Deruxtecan (T-DXd) is a novel antibody-drug conjugate that targets human epidermal growth factor receptor 2 (HER2) with a DNA topoisomerase I inhibitor payload and has demonstrated antitumor activity in clinical trials. Based
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::caa3c18ec8ae603417b53ee0440ee0e6
https://doi.org/10.1158/1538-7445.sabcs21-ot1-12-08
https://doi.org/10.1158/1538-7445.sabcs21-ot1-12-08
Autor:
Kazuo Matsuura, Junji Tsurutani, Kenichi Inoue, Yuko Tanabe, Tetsuhiko Taira, Kaoru Kubota, Tomohide Tamura, Toshiaki Saeki
Publikováno v:
Cancer. 128:1692-1698
Fosnetupitant (FosNTP), an intravenous neurokinin 1 receptor antagonist, demonstrated a favorable safety profile with a potentially low risk of injection site reactions (ISRs) and promising antiemetic efficacy in patients receiving cisplatin-based hi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ffad6951eb106f8237682bb1f158aa12
https://doi.org/10.1002/cncr.34088
https://doi.org/10.1002/cncr.34088
Autor:
Yusuke Tanigawara, Takahisa Kawamura, Akira Ono, Kazuhisa Nakashima, Tateaki Naito, Chiyo K. Imamura, Toshiaki Takahashi, Tetsuhiko Taira, Haruyasu Murakami, Kazushige Wakuda, Shota Omori, Taisei Mushiroda, Hirotsugu Kenmotsu
Publikováno v:
Cancer Chemotherapy and Pharmacology. 85:605-614
Severe hepatotoxicity induced by the standard dose of gefitinib (250 mg daily) often becomes manageable by dose reduction to 250 mg every other day. Thus, we hypothesized that systemic exposure of standard-dose gefitinib in patients with experience o
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::480daf150d3b0ff3eebb17ab19e27a90
https://doi.org/10.1007/s00280-020-04034-y
https://doi.org/10.1007/s00280-020-04034-y
Autor:
Hirotsugu Kenmotsu, Chiyo K. Imamura, Takahisa Kawamura, Takuya Oyakawa, Shota Omori, Kazuhisa Nakashima, Kazushige Wakuda, Akira Ono, Tetsuhiko Taira, Tateaki Naito, Haruyasu Murakami, Nobuyuki Yamamoto, Toshiaki Takahashi, Yusuke Tanigawara
Publikováno v:
Cancer chemotherapy and pharmacology. 90(2)
To evaluate the relationship between treatment efficacy and exposure of total and unbound erlotinib in patients with non-small cell lung cancer (NSCLC) harboring epidermal growth factor receptor (EGFR)-activating mutations.EGFR-tyrosine kinase inhibi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::296bd4d106a4a464c6100128d9de5f2d
https://pubmed.ncbi.nlm.nih.gov/35821437
https://pubmed.ncbi.nlm.nih.gov/35821437
Autor:
Hisao Imai, Ryo Ko, Akira Ono, Masaru Watanabe, Masahiro Endo, Toshiaki Takahashi, Tetsuhiko Taira, Haruyasu Murakami, Yasuhiro Koh, Takashi Nakajima, Masato Abe, Kazushige Wakuda, Tateaki Naito, Hirotsugu Kenmotsu
Publikováno v:
Cancer Science
Circulating tumor cells (CTCs) are a tumor-derived material utilized for liquid-based biopsy; however, capturing rare CTCs for further molecular analysis remains technically challenging, especially in non-small-cell lung cancer. Here, we report the r
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::84945ea9d101b057444b6cf8adf45dd1
http://europepmc.org/articles/PMC6113429
http://europepmc.org/articles/PMC6113429